Fund Holdings — Fairmount Funds Management LLC

Total Portfolio Value:
$1.01B
Total Bought:
$142.14M
Total Sold:
$196.73M
Net Transaction:
-$54.59M
Notable People:
Tomas Kiselak, Peter Evan Harwin
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Axsome Therapeutics, Inc.(AXSM)2,360,0771,468,983-891,094$212.10M$124.29M12.36%-$87.81M
Nuvalent Inc1,687,0641,317,664-369,400$172.59M$103.15M10.25%-$69.44M
Spyre Therapeutics, Inc.(SYRE)4,018,1014,018,1010$118.17M$93.54M9.30%-$24.63M
Apogee Therapeutics Inc2,048,6472,048,6470$120.34M$92.80M9.23%-$27.53M
Scholar Rock Holding Corporation(SRRK)01,962,953+1,962,953$0$84.84M8.43%+$84.84M
Enliven Therapeutics Inc3,202,7983,202,7980$81.80M$72.06M7.16%-$9.74M
Viridian Therapeutics, Inc.(VRDN)3,445,8133,445,8130$78.39M$66.06M6.57%-$12.34M
Oruka Therapeutics, Inc.(ORKA)3,211,9223,371,922+160,000$78.72M$65.38M6.50%-$13.34M
Dianthus Therapeutics, Inc.(DNTH)2,700,6912,700,6910$73.94M$58.88M5.85%-$15.07M
Cogent Biosciences, Inc.(COGT)6,225,6416,225,6410$67.24M$48.56M4.83%-$18.68M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)3,204,8412,194,341-1,010,500$80.09M$43.40M4.32%-$36.68M
Day One Biopharmaceuticals Inc
COM
3,103,4483,103,4480$43.23M$39.32M3.91%-$3.91M
Astria Therapeutics Inc3,554,1293,554,1290$39.13M$31.77M3.16%-$7.36M
Anaptysbio Inc01,816,466+1,816,466$0$24.05M2.39%+$24.05M
Bicara Therapeutics Inc1,284,1691,284,1690$32.71M$22.37M2.22%-$10.34M
Inhibikase Therapeutics, Inc.(IKT)06,125,000+6,125,000$0$19.91M1.98%+$19.91M
Zenas BioPharma, Inc.(ZBIO)1,892,8061,892,8060$32.03M$15.50M1.54%-$16.52M
Bicycle Therapeutics PlcADS123,5380-123,538$2.80M$0—-$2.80M
Page 1 of 1
Fairmount Funds Management LLC — 13F Holdings — Q4 2024 | TickerTrail